(Q39991911)

16 September 2017

title

High-throughput lung cancer cell line screening for genotype-correlated sensitivity to an EGFR kinase inhibitor (English)

1 reference

16 September 2017

0 references

1 reference

1 reference

1

0 references

author name string

Sreenath V Sharma

series ordinal

2

1 reference

16 September 2017

Jeffrey Settleman

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

16 September 2017

published in

Methods in Enzymology

1 reference

16 September 2017

volume

438

1 reference

16 September 2017

page(s)

331-341

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2938023-3

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2938023-3

7 January 2021

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2938023-3

7 January 2021

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2938023-3

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2807%2938023-3

7 January 2021

10.1016/S0076-6879(07)38023-3

Identifiers

DOI

1 reference

16 September 2017

1 reference